임신 중 sodium salicylate을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

sodium salicylate은 임신 중 안전한가요?

Harmonised EU classification: Repr. 2 H361d (suspected of damaging the unborn child) is assigned for salicylates by ECHA/CLP (harmonised classification). Animal studies (rat) report teratogenic and reproductive effects following oral exposure to sodium/salicylic acid; salicylates cross biological barriers and altered pharmacokinetics in pregnancy have been reported, so a demonstrated mechanism (COX/prostaglandin interference and placental transfer) supports a suspected reproductive hazard. For topical cosmetic use, systemic absorption of salicylates is measurable but typically low — therefore exposure is scored as low but non-negligible for pregnant adults. Sources: ECHA harmonised classification and substance pages, CIR salicylic acid/salicylates assessment, and rat developmental studies.

sodium salicylate은 모유 수유 중 안전한가요?

Because of the harmonised Repr.2 (H361d) and animal evidence of reproductive/developmental effects, sodium salicylate is flagged for nursing mothers. Salicylates are systemically available after absorption and can be transferred to milk; mechanism evidence (systemic salicylate activity, prostaglandin/COX effects) is demonstrated in animals. Topical cosmetic use typically gives low but measurable systemic exposure, so exposure scoring is 1 for breastfeeding mothers.

sodium salicylate은 아기 피부에 안전한가요?

Hazard and mechanistic scores follow adult reproductive evidence (harmonised H361d and animal teratogenicity). Per instructions, exposure (e) is increased by +1 for infants 0–3 years because infant skin has higher absorption; salicylates are known to be percutaneously absorbed and systemic exposure from topical use can occur, so baby skin exposure is moderate. There is no infant-specific study showing higher intrinsic hazard, so h/m remain based on the existing reproductive evidence.

VeriMom은 sodium salicylate을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 sodium salicylate을 20/100 (높은 위험)로 평가합니다.

임신 중 sodium salicylate 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.